Histidine decarboxylase inhibition attenuates cancer-associated muscle wasting
Journal of Experimental Medicine · 01.09.2025 · 222 (9)
DOI: 10.1084/jem.20242239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 02.07.2025. Verfasst von Aneesha Dasgupta und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, IN, USA. Hauptthemen laut MEDLINE: Histidine Decarboxylase, Cachexia, Muscular Atrophy, Pancreatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Cancer Institute Cancer Center, NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Cancer cachexia is a multifactorial syndrome involving muscle and fat wasting, inflammation, and metabolic dysfunction. Across cancer subtypes, pancreatic cancer has one of the highest cachexia incidence rates at ∼80%. Given the advanced age of most pancreatic cancer patients, we sought to query cancer-associated muscle wasting using an age-matched murine model. We found that histamine and histamine decarboxylase (HDC) activity were specifically elevated in the muscles of aged tumor-bearing mice. We further found that (1) wasting stimuli induced histamine production and enhanced HDC activity; (2) exogenous histamine was sufficient to induce atrophy-associated gene expression; (3) inhibition of HDC activity by α-fluoromethylhistidine (FMH) protected against atrophy; (4) treatment of tumor-bearing mice with FMH rescued muscle wasting; and (5) a calcineurin inhibitor was able to rescue histamine-associated increases in calcium/atrogene signaling. In summary, we present a novel metabolic pathway that has significant implications for the treatment of cachectic cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, IN, USA.
- Indiana University Simon Comprehensive Cancer Center , Indianapolis, IN, USA.
- Indiana Center for Musculoskeletal Health , Indianapolis, IN, USA.
- Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
- Mayo Clinic , Rochester, MN, USA.
- Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center , Omaha, NE, USA.
ORCID-Profile: Aneesha Dasgupta, Rebecca E Schmitt, Tatsuyoshi Kono, Chih-Chun Lee, Mark I Zoberi, Savannah A Epstein, Jessica Z Schneider, Alejandro Hernandez, Paul M Grandgenett, Thomas C Caffrey, Dominick J DiMaio, Michael A Hollingsworth, Jason D Doles
Förderung
- National Cancer Institute Cancer Center
- NCI NIH HHS
- NIH HHS
- NIDDK NIH HHS
- Indiana University
- Pancreatic Cancer Detection Consortium
- Mayo Clinic
- American Association for Cancer Research
Zitieren
APA
Dasgupta, A., Schmitt, R. E., Kono, T., Lee, C. C., Zoberi, M. I., Epstein, S. A., Schneider, J. Z., Hernandez, A., Grandgenett, P. M., Caffrey, T. C., DiMaio, D. J., Hollingsworth, M. A., & Doles, J. D. (2025). Histidine decarboxylase inhibition attenuates cancer-associated muscle wasting. Journal of Experimental Medicine, 222(9). https://doi.org/10.1084/jem.20242239
Vancouver
Dasgupta A, Schmitt RE, Kono T, Lee CC, Zoberi MI, Epstein SA, et al. Histidine decarboxylase inhibition attenuates cancer-associated muscle wasting. Journal of Experimental Medicine. 2025;222(9). doi:10.1084/jem.20242239
BibTeX
@article{Dasgupta2025,
author = {Dasgupta, Aneesha and Schmitt, Rebecca E and Kono, Tatsuyoshi and Lee, Chih-Chun and Zoberi, Mark I and Epstein, Savannah A and Schneider, Jessica Z and Hernandez, Alejandro and Grandgenett, Paul M and Caffrey, Thomas C and DiMaio, Dominick J and Hollingsworth, Michael A and Doles, Jason D},
title = {Histidine decarboxylase inhibition attenuates cancer-associated muscle wasting},
journal = {Journal of Experimental Medicine},
year = {2025},
volume = {222},
number = {9},
doi = {10.1084/jem.20242239}
}
EUVIMED